233
Participants
Start Date
May 31, 2007
Primary Completion Date
July 31, 2016
Study Completion Date
November 29, 2017
mycophenolate mofetil
Patients randomized in this group will receive 750 mg of MMF per os twice a day starting on the day of transplant. MMF dose will be reduced in case of white blood cell count lower than 2,000/mm3 and whenever deemed clinically appropriate.
azathioprine
Patients randomized in this group will receive 75 mg of AZA per os (or 125 mg if body weight \> 75 kg) once a day starting on the day of transplant. AZA dose will be reduced in case of white blood cell count lower than 2,000/mm3 and whenever deemed clinically appropriate.
"Hospital Azienda Ospedaliera Ospedali Riuniti di Bergamo Unit of Neprology and Dialysis", Bergamo
"Hospital Spedali Civili - Unit of Nephrology and Dialysis", Brescia
"Hospital Niguarda Cà Granda", Milan
"Hospital Azienda Ospedaliera di Padova -", Padua
Policlinico Gemelli, Roma
"Hospital Az. Ospedaliero-Univeristaria S. Maria della Misericordia", Udine
Agenzia Italiana del Farmaco
OTHER_GOV
Mario Negri Institute for Pharmacological Research
OTHER